Any thoughts as to VIDA's potential for profit??
Friday July 23, 11:27 am Eastern Time
Company Press Release
SOURCE: VidaMed, Inc.
VidaMed Realigns Outside Sales Efforts; Designates Eight Account Specialists to Accelerate New Business Development
FREMONT, Calif., July 23 /PRNewswire/ -- VidaMed, Inc. (Nasdaq: VIDA - news) announced today that it has realigned the existing sales organization to expand it sales efforts and designated eight (8) Account Specialists focusing on new business development. The Company has increased efforts to build product utilization, increase consumer awareness and accelerate the establishment of TUNA-trained physicians. VidaMed's TUNA (Transurethral Needle Ablation) System treats symptoms associated with BPH (Benign Prostatic Hyperplasia), commonly referred to as enlarged prostate disease.
The Company said that the Account Specialists would provide marketing assistance to urologists at the local level. They will assist urologists to locate men with prostate health concerns though advertising, health fairs, and information resources available through the Internet. Additionally, the Account Specialists will help identify local family practitioners that treat men seeking drug treatment for enlarged prostate through their primary care physicians.
''With the significant increase in Medicare coverage from states this year, which to date totals 38 states, or 71% of VidaMed's target population, VidaMed has been able to attract a significant number of new, as well reactivate existing sites offering the TUNA treatment,'' said Randy Lindholm, who will become President and Chief Executive Officer August 1st.''
Lindholm added, ''We believe that increasing familiarity on behalf of urologists coupled with increased Medicare coverage for the TUNA Procedure is beginning to result in more men taking advantage of the benefits of TUNA. Our Account Specialists will help accelerate this process by providing opportunities for building relationships between the urologist and patients. Also, the Account Specialist frees VidaMed's sales team to focus on introducing new urologists to the TUNA System and establish programs for its use at hospitals.''
VidaMed designs, develops and markets technology and clinically advanced cost-effective systems for the treatment of urological conditions. VidaMed is headquartered in the Silicon Valley in Fremont, California.
Certain statements in this news release, including statements relating to the demand for the TUNA Procedure, contain forward-looking information. Actual results may vary significantly from those anticipated in such forward-looking statements due to risks and uncertainties, including the rate of adoption of the TUNA Procedure by the medical community, the impact of competitive treatments, products and pricing, the development and effectiveness of the Company's sales organization and marketing efforts, and other risks, including those set forth in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on April 17, 1999. The Company's actual results may differ significantly from the results anticipated by the forward- looking statements as a result of these or other factors.
For additional patient information and VidaMed's physician referral service, please call 800-328-8781. For Investor Information on VidaMed, Inc. at no cost, please call 888-301-2498 or order it from VidaMed's website at vidamed.com.
SOURCE: VidaMed, Inc. |
